The association between erectile dysfunction and cardiovascular risk in men with Type 2 diabetes in primary care: it is a matter of age

Journal of Diabetes and Its Complications
Frits G W CleveringaGuy E H M Rutten

Abstract

Erectile dysfunction (ED) prevalence is usually based on questionnaires, too elaborate for daily practice. The single question for ED prevalence is unknown. Literature reports an independent association between ED and both cardiovascular disease (CVD) and diabetes. Whether routinely asking men with Type 2 diabetes (DM2) about ED identifies those at elevated risk for CVD is unknown. We assessed cardiovascular risk of DM2 men with ED. This was a cross-sectional study in primary care. During annual check-up, the practice nurse asked 1823 DM2 men: "Do you have erection problems? Yes/no." ED prevalence rate was calculated. Age, medication, and other known factors associated with ED and/or CVD were used in univariate analysis (odds ratio [OR], Student's t test, and Mann-Whitney test). This revealed confounding variables used in the multivariable analysis. The association between ED and history of cardiovascular disease (HCVD) was assessed by logistic regression analysis. In patients with no HCVD, we assessed the association between ED and 10-year United Kingdom Prospective Diabetes Study (UKPDS) coronary heart disease risk by linear regression analysis. The prevalence of ED in DM2 patients was 41.3%. There was no independent associat...Continue Reading

References

May 1, 1994·Journal of Clinical Epidemiology·H A FeldmanJ B McKinlay
Feb 1, 1993·Archives of Sexual Behavior·K Solstad, P Hertoft
Jul 7, 1993·JAMA : the Journal of the American Medical Association
Jan 16, 1998·Journal of Psychosomatic Research·O E el-RufaieT A Ali
May 12, 2001·Journal of the American Geriatrics Society·M H BlankerJ L Bosch
Nov 29, 2001·Clinical Science·R J StevensUNKNOWN United Kingdom Prospective Diabetes Study (UKPDS) Group
Jan 30, 2002·Diabetes Care·Giorgia De BerardisUNKNOWN Quality of Care and Outcomes in Type 2 Diabetes (QuED) Study Group
Aug 2, 2002·International Journal of Impotence Research·R C RosenN Gendrano
Dec 21, 2002·International Journal of Impotence Research·J PrinsJ L H R Bosch
Apr 5, 2003·Diabetic Medicine : a Journal of the British Diabetic Association·P K Moulik, K J Hardy
Feb 13, 2004·International Journal of Impotence Research·B J de BoerTh J M Verheij
Feb 20, 2004·International Journal of Impotence Research·B J de BoerTh J M Verheij
Feb 27, 2004·International Journal of Impotence Research·W A BlumentalsV Vannappagari
Apr 28, 2005·International Journal of Clinical Practice·M KirbyU Simonsen
Jul 1, 2005·Journal of General Internal Medicine·Amy B O'DonnellJohn B McKinlay
Jan 18, 2006·JAMA : the Journal of the American Medical Association·Ian M ThompsonCharles A Coltman
Jan 25, 2006·Archives of Internal Medicine·James K MinR Parker Ward
Sep 16, 2009·Annals of Family Medicine·Erwin P Klein WoolthuisChris van Weel

❮ Previous
Next ❯

Citations

May 21, 2010·Reproductive Biology and Endocrinology : RB&E·Marzieh Ziaei-RadAli Montazeri
Mar 27, 2012·Primary Care Diabetes·Rodrigo Jiménez-GarciaPilar Carrasco-Garrido
Aug 6, 2011·Archives of Toxicology·Todd L WattersonRoger A Coulombe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Related Papers

Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease
Seyedeh Seddigeh Fatemi, Seyed Morteza Taghavi
Diabetes Care
Giorgia De BerardisQuED (Quality of Care and Outcomes in Type 2 Diabetes) Study Group
© 2022 Meta ULC. All rights reserved